JP2020517663A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517663A5
JP2020517663A5 JP2019557486A JP2019557486A JP2020517663A5 JP 2020517663 A5 JP2020517663 A5 JP 2020517663A5 JP 2019557486 A JP2019557486 A JP 2019557486A JP 2019557486 A JP2019557486 A JP 2019557486A JP 2020517663 A5 JP2020517663 A5 JP 2020517663A5
Authority
JP
Japan
Prior art keywords
tyrosine
methyl
amino
propanoate
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557486A
Other languages
English (en)
Japanese (ja)
Other versions
JP7171611B2 (ja
JP2020517663A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/028552 external-priority patent/WO2018195411A1/en
Publication of JP2020517663A publication Critical patent/JP2020517663A/ja
Publication of JP2020517663A5 publication Critical patent/JP2020517663A5/ja
Application granted granted Critical
Publication of JP7171611B2 publication Critical patent/JP7171611B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019557486A 2017-04-21 2018-04-20 網膜症を治療するための組成物及び方法 Active JP7171611B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762488161P 2017-04-21 2017-04-21
US62/488,161 2017-04-21
PCT/US2018/028552 WO2018195411A1 (en) 2017-04-21 2018-04-20 Compositions and methods for treating retinopathy

Publications (3)

Publication Number Publication Date
JP2020517663A JP2020517663A (ja) 2020-06-18
JP2020517663A5 true JP2020517663A5 (cg-RX-API-DMAC7.html) 2021-05-06
JP7171611B2 JP7171611B2 (ja) 2022-11-15

Family

ID=62117055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019557486A Active JP7171611B2 (ja) 2017-04-21 2018-04-20 網膜症を治療するための組成物及び方法

Country Status (11)

Country Link
US (2) US11351136B2 (cg-RX-API-DMAC7.html)
EP (1) EP3612225A1 (cg-RX-API-DMAC7.html)
JP (1) JP7171611B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190138683A (cg-RX-API-DMAC7.html)
CN (1) CN110769855A (cg-RX-API-DMAC7.html)
AU (1) AU2018254556B2 (cg-RX-API-DMAC7.html)
CA (1) CA3060417A1 (cg-RX-API-DMAC7.html)
EA (1) EA201992515A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019012476A (cg-RX-API-DMAC7.html)
PH (1) PH12019502380A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018195411A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3968785A4 (en) 2019-05-14 2023-01-11 Tyme, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451422A1 (en) * 1990-04-13 1991-10-16 Merrell Dow Pharmaceuticals Inc. Pharmaceutically active fluoromethyltyrosine compounds
MXPA02002559A (es) * 1999-09-10 2002-07-30 Merck & Co Inc Inhibidores de tirosina cinasa.
JP4758581B2 (ja) 1999-11-30 2011-08-31 アルコン,インコーポレイテッド 外網膜の疾患を処置する薬剤を製造するためのβ−アドレナリン作用受容体アンタゴニストの使用
AP2001002359A0 (en) 2000-11-30 2001-12-31 Pfizer Prod Inc Combination of gaba agonists and aldose reductase inhibitors.
NZ552816A (en) 2007-01-24 2009-05-31 Bomac Research Ltd Formulation for transdermal administration of antihyperthyroid drug comprising a penetration enhancer selected from oleic acid, d-limonene, pyrrolidones, a C2-C8 alcohol, glycol ethers, triacetin and combinations thereof
EP2114386B9 (en) 2007-01-29 2013-09-18 Vlife Sciences Technologies Pvt Ltd. Pharmaceutical composition for treatment of diabetic complications
AU2008347005B2 (en) 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
US20100204325A1 (en) 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
WO2013109610A1 (en) * 2012-01-17 2013-07-25 Steven Hoffman Pharmaceutical compositions and methods
US9962362B2 (en) 2012-03-29 2018-05-08 Children's Hospital Medical Center Use of small molecule inhibitors targeting EYA tyrosine phosphatase
US20150111878A1 (en) 2013-10-22 2015-04-23 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) * 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
JP6836991B2 (ja) 2014-12-23 2021-03-03 スティーブン・ホフマン 経皮製剤
US9687528B2 (en) 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations

Similar Documents

Publication Publication Date Title
US20220000824A1 (en) Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acid
RU2671208C2 (ru) Композиции, содержащие 15-он эпк, и способы их применения
JP2021001194A (ja) 腸透過性亢進を治療するための組成物及び方法
JP5810166B2 (ja) 糖尿病性心血管合併症の予防・治療剤
EP3668500A1 (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel
KR102000332B1 (ko) 간내 담즙정체성 질환의 치료
EA030314B1 (ru) Составы для уменьшения содержания жира
RU2204388C2 (ru) ИБУПРОФЕНОВЫЙ ТИОЭФИР В КАЧЕСТВЕ ИНГИБИТОРА, ЗАВИСЯЩЕГО ОТ Nf-kB ОБРАЗОВАНИЯ МЕДИАТОРОВ ВОСПАЛЕНИЯ И БОЛИ
CN107835695A (zh) 用于治疗自闭症的组合物和方法
Scheman Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report
JP2019516709A5 (cg-RX-API-DMAC7.html)
CN113613640B (zh) 肾上腺素能β2受体激动剂R-对映体在治疗炎症性肠病及其肠外疾病的新应用
US12364676B2 (en) Compositions and methods for treating retinopathy
KR20120089623A (ko) 정맥내 투여용 이부프로펜을 이용한 환자의 치료
ES2250749T3 (es) Uso de una composicion combinada que comprende propionil l-carnitina y otros farmacos para el tratamiento de la disfuncion erectil.
JP7442263B2 (ja) 白血球の接着を阻害する医薬の調製におけるトリアセチル-3-ヒドロキシフェニルアデノシンの使用
Smirnov et al. FRI0412 Spinal and sacroiliac joints inflammation in patients with radiographic axial spondyloarthritis treated with netakimab–16-weeks results of multicenter, randomized, double-blind, placebo-controlled phase III ASTERA study
CN106983738B (zh) 甲状腺激素及其药学上可接受的盐或前药在制备治疗和/或预防皮肤疾病的药物中的应用
RU2704109C2 (ru) Комбинация ретиноида и диола и эфира полиненасыщенной жирной кислоты
JP2011032262A (ja) Nsaidの長期使用のための医薬組成物
WO2025137024A1 (en) Methods of treating cardiovascular disease associated with calcification
JP2026509094A (ja) 尿毒症性掻痒の治療
WO2024040256A2 (en) Pharmaceutical combinations and methods for preventing or treating neurodegenerative diseases
RU2021130172A (ru) Способы лечения пограничного расстройства личности
WO2012104846A1 (en) Ras inhibitors for treating diseases or pathological conditions characterized insulin resistance